Background: Factor XII (FXII) Locarno is a natural variant with proline replacing Arg353
| INTRODUCTION
Exposure of blood to a variety of biological and non-biological substances or surfaces initiates contact activation. Central to this process is the plasma protein factor XII (FXII), the precursor of the serine protease α-factor XIIa (α-FXIIa).
1 In blood plasma, α-FXIIa activates the kallikreinkinin system by converting plasma prekallikrein (PK) to α-kallikrein, 2 and
initiates coagulation by activating factor XI (FXI). 3 It is well-recognized that FXII undergoes autocatalysis to α-FXIIa by cleavage after Arg353 upon surface binding, 4 however, the mechanism that initiates this process has been debated. Recently, we showed that FXII restricted to the single-chain precursor form (sc-FXII) by replacement of Arg353 with alanine still expresses proteolytic activity toward FXII, PK, and FXI in the presence of anionic cofactors such as polyphosphate (Poly-P). 5 While the activity of sc-FXII is orders of magnitude lower than that of α-FXIIa, it would provide a triggering mechanism for contact activation.
FXII-Locarno is a cross-reactive material positive FXII variant that contains proline in place of Arg353 (FXII-R353P). It was identified in a patient with a prolonged activated partial thromboplastin time (aPTT) and no bleeding symptoms. 6, 7 Like FXII-R353A, FXII-R353P cannot be converted to α-FXIIa, and was initially thought to lack proteolytic activity. 6, 7 We compared the activities of FXII containing FXII-R353A
and FXII-R353P, to determine if the non-conservative proline substitution at the activation cleavage site altered the activity of sc-FXII.
| METHODS

| Materials
Pooled normal plasma (PNP), Precision Biologic. FXII-deficient plasma (FXII-dp), George King. FXII, PK, α-kallikrein high molecular weight kinnogen (HK) and corn trypsin inhibitor (CTI), Enzyme Research Lab (South Bend, IN, USA). PTT-A, Diagnostica Stago (Parsippany, NJ, were prepared by site-directed mutagenesis. NaCl, 0.1% PEG-8000, 10 μmol L −1 ZnCl 2 ) was incubated at 37°C with or without 70 μmol L −1 Poly-P (total phosphate group concentration).
| Recombinant proteins
| Western blots
At various times, aliquots were removed into reducing SDS-sample buffer, size fractionated by SDS-PAGE and evaluated by western blot using goat anti-human FXIl IgG. Detection was with HRP conjugated rabbit anti-goat IgG and chemiluminescence.
| Chromogenic assays
Reactions 
| Thrombin generation
Thrombin generation was measured in plasma as described. 14, 15 FXII-dp (80 μL) containing 415 μmol L −1 Z-Gly-Gly-Arg-AMC (Bachem, Torrance, CA, USA) was reconstituted with FXII (400 nmol L converted to thrombin generated using the manufacturers software.
Assays were performed in triplicate. Endogenous thrombin potential (ETP-area under the curve, reported in nm.min) was determined using GraphPad Prism software.
| Plasma clotting assays
aPTT assays were performed on a STart4 Coagulation Analyzer (Diagnostica Stago). PNP or FXII-dp supplemented with vehicle or FXII were tested, using PTT-A reagent to trigger contact activation. Assays were performed in triplicate.
| RESULTS AND DISCUSSION
FXII-Locarno (FXII-R353P) is not converted to α-FXIIa because proline replaces arginine at the activation cleavage site (Arg353-Val354 bond). 6, 7 We compared it to the previously described FXII-R353A to determine the effects of Pro353 on the intrinsic activity of sc-FXII. α-FXIIa promotes thrombin generation in plasma by activating FXI, a homolog of PK. 3 We assessed the capacity of FXII to activate FXI using thrombin generation assays. Little thrombin generation occurs when FXII species are added to FXII-dp in the absence of an inducer of contact activation ( Figure 3A , left). We compared FXI-WT, FXII-R353A, FXII-R353P in aPTT assays, which also require FXI activation by contact activation. In Figure 3B , aPTTs of PNP (36.4 ± 2.1 seconds) and FXII-dp (271 ± 5.1 seconds) are shown as white bars, while yellow bars show the effects of FXII-WT on the aPTT of FXII-dp, up to the normal plasma FXII concentration (400 nmol L −1
). FXII-R353A and FXII-R353P shorten the aPTT of FXII-dp slightly, with effects equivalent to <1% of the activity of FXII-WT. This supports the premise that it is α-FXIIa that is primarily responsible for FXI activation in normal plasma in the aPTT. The effect of FXII-R353A
was significantly greater than FXII-R353P (206.2 ± 6.1 vs 256.5 ± 3.3, respectively, P < .05). Taken as a whole, the data with PK activation and thrombin generation assays, and the aPTT data, suggest that proline at position 353 in FXII has a deleterious effect on sc-FXII activity. . White bars show average aPTTs for PNP and FXII-dp plasma. Yellow bars are average aPTTs for FXII-dp supplemented with varying concentrations of FXII-WT (0.78 to 400 nmol L −1
). The blue and green bars are FXII-dp supplemented with 400 nmol L −1 FXII-R353A or FXII-R353P, respectively. Results are presented as mean of three separate runs and the error bars represent standard deviations. *P < .05
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